Reply to thread

Message

<blockquote data-quote="tD33NAt" data-source="post: 2091738" data-attributes="member: 124445">Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, announced that Chugai Pharmaceutical Co., Ltd. (TSE: 4519) has exercised its right of first refusal for the development and commercialization in Japan of GDC-0449, a Hedgehog pathway inhibitor, under an existing agreement with F. Hoffmann-La Roche, Ltd (SIX: RO, ROG; OTCQX: RHHBY). GDC-0449 is being developed by Genentech, Inc., a wholly owned member of the Roche Group, under the 2003 collaboration agreement between Genentech and Curis...<a href="http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a><a href="http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/9kV-LXRTYEQ" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/9kV-LXRTYEQ/3xST" target="_blank">More...</a></blockquote>

[QUOTE="tD33NAt, post: 2091738, member: 124445"] Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, announced that Chugai Pharmaceutical Co., Ltd. (TSE: 4519) has exercised its right of first refusal for the development and commercialization in Japan of GDC-0449, a Hedgehog pathway inhibitor, under an existing agreement with F. Hoffmann-La Roche, Ltd (SIX: RO, ROG; OTCQX: RHHBY). GDC-0449 is being developed by Genentech, Inc., a wholly owned member of the Roche Group, under the 2003 collaboration agreement between Genentech and Curis...[URL="http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/0/da"][IMG]http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/1/da"][IMG]http://feedads.g.doubleclick.net/~a/ZG-rTzjg9ECuvsHtiMvhcwXM6k4/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/9kV-LXRTYEQ[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/9kV-LXRTYEQ/3xST]More...[/url] [/QUOTE]

Name

Verification

Loading…